MedTrace Logo

Identification/Characterization of Changes in Microscopic Colitis

NCT03063957 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 330

Last updated 2021-09-01

No results posted yet for this study

Summary

The goal of this study is to establish a prospective observational cohort of adult patients with microscopic colitis and collect clinical information and specimens over the course of their treatment. This information will be used in order to establish a patient registry with detailed clinical data and a specimen repository for future research as well as to specifically identify genetic and molecular characteristics associated with microscopic colitis.

Conditions

  • Colitis, Microscopic

Sponsors & Collaborators

  • Takeda Pharmaceuticals North America, Inc.

    collaborator INDUSTRY

  • American College of Gastroenterology

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Hamed Khalili, MD · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2023-07-31
Completion
2024-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03063957 on ClinicalTrials.gov